Alkermes plc - Ordinary Shares (ALKS): Price and Financial Metrics
GET POWR RATINGS... FREE!
ALKS POWR Grades
- ALKS scores best on the Value dimension, with a Value rank ahead of 92.48% of US stocks.
- ALKS's strongest trending metric is Momentum; it's been moving up over the last 179 days.
- ALKS's current lowest rank is in the Momentum metric (where it is better than 24.37% of US stocks).
ALKS Stock Summary
- ALKERMES PLC's stock had its IPO on July 16, 1991, making it an older stock than 85.1% of US equities in our set.
- The price/operating cash flow metric for ALKERMES PLC is higher than 95.11% of stocks in our set with a positive cash flow.
- Over the past twelve months, ALKS has reported earnings growth of 91.09%, putting it ahead of 84.15% of US stocks in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to ALKERMES PLC are DZSI, PEAR, PTE, EMKR, and SQL.
- Visit ALKS's SEC page to see the company's official filings. To visit the company's web site, go to www.alkermes.com.
ALKS Valuation Summary
- ALKS's EV/EBIT ratio is -30.6; this is 455.81% lower than that of the median Healthcare stock.
- ALKS's price/earnings ratio has moved down 27.1 over the prior 243 months.
Below are key valuation metrics over time for ALKS.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| ALKS | 2022-11-25 | 3.5 | 3.8 | -30.8 | -30.6 |
| ALKS | 2022-11-23 | 3.5 | 3.8 | -30.9 | -30.7 |
| ALKS | 2022-11-22 | 3.6 | 3.9 | -31.2 | -30.9 |
| ALKS | 2022-11-21 | 3.4 | 3.7 | -30.2 | -30.0 |
| ALKS | 2022-11-18 | 3.4 | 3.7 | -29.8 | -29.6 |
| ALKS | 2022-11-17 | 3.3 | 3.6 | -28.7 | -28.6 |
ALKS Growth Metrics
- Its 2 year net income to common stockholders growth rate is now at 55.61%.
- The 4 year revenue growth rate now stands at 60.13%.
- Its 2 year revenue growth rate is now at 0.57%.
The table below shows ALKS's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-09-30 | 1,131.584 | 51.018 | -129.14 |
| 2022-06-30 | 1,173.368 | 133.17 | -94.154 |
| 2022-03-31 | 1,200.866 | 168.539 | -61.654 |
| 2021-12-31 | 1,173.751 | 101.715 | -48.169 |
| 2021-09-30 | 1,129.283 | 138.037 | -91.684 |
| 2021-06-30 | 1,100.154 | 115.463 | -62.83 |
ALKS's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- ALKS has a Quality Grade of B, ranking ahead of 88.71% of graded US stocks.
- ALKS's asset turnover comes in at 0.582 -- ranking 63rd of 680 Pharmaceutical Products stocks.
- OTLK, AVEO, and LXRX are the stocks whose asset turnover ratios are most correlated with ALKS.
The table below shows ALKS's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-09-30 | 0.582 | 0.835 | -0.047 |
| 2021-06-30 | 0.576 | 0.836 | -0.029 |
| 2021-03-31 | 0.556 | 0.835 | -0.050 |
| 2020-12-31 | 0.557 | 0.828 | -0.061 |
| 2020-09-30 | 0.641 | 0.845 | -0.034 |
| 2020-06-30 | 0.646 | 0.844 | -0.076 |
ALKS Price Target
For more insight on analysts targets of ALKS, see our ALKS price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $26.50 | Average Broker Recommendation | 1.88 (Hold) |
ALKS Stock Price Chart Interactive Chart >
ALKS Price/Volume Stats
| Current price | $26.09 | 52-week high | $32.79 |
| Prev. close | $25.20 | 52-week low | $21.75 |
| Day low | $24.85 | Volume | 1,978,400 |
| Day high | $26.17 | Avg. volume | 1,541,865 |
| 50-day MA | $23.15 | Dividend yield | N/A |
| 200-day MA | $26.13 | Market Cap | 4.29B |
Alkermes plc - Ordinary Shares (ALKS) Company Bio
Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. The company was founded in 1987 and is based in Dublin, Ireland.
Latest ALKS News From Around the Web
Below are the latest news stories about ALKERMES PLC that investors may wish to consider to help them evaluate ALKS as an investment opportunity.
Alkermes Supporting Local CommunitiesAlkermes respects the culture, customs and values of the people in the communities in which we operate. |
Biotech Hasn't Been This Blazing Hot Since Early 2021 — Here Are The Top 5The top five biotech stocks today have several commonalities: strong ratings. Some also show promising charts and are Tech Leaders. |
How Alkermes (ALKS) Stock Stands Out in a Strong IndustryAlkermes (ALKS) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well. |
Alkermes to Participate in the 5th Annual Evercore ISI HealthCONx ConferenceDUBLIN , Nov. 22, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the 5th Annual Evercore ISI HealthCONx Conference on Tuesday, Nov. 29, 2022 at 2:40 p.m. ET ( 7:40 p.m. GMT ). The live webcast may be accessed under the |
Alkermes plc: Alkermes to Participate in the 5th Annual Evercore ISI HealthCONx ConferenceDUBLIN, Nov. 22, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the 5th Annual Evercore ISI HealthCONx Conference on Tuesda… |
ALKS Price Returns
| 1-mo | 8.44% |
| 3-mo | 6.45% |
| 6-mo | -10.99% |
| 1-year | 18.00% |
| 3-year | 28.78% |
| 5-year | -51.42% |
| YTD | 12.17% |
| 2021 | 16.59% |
| 2020 | -2.21% |
| 2019 | -30.87% |
| 2018 | -46.08% |
| 2017 | -1.53% |
Continue Researching ALKS
Want to see what other sources are saying about Alkermes plc's financials and stock price? Try the links below:Alkermes plc (ALKS) Stock Price | Nasdaq
Alkermes plc (ALKS) Stock Quote, History and News - Yahoo Finance
Alkermes plc (ALKS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...